Comment Resolutions: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 59: | Line 59: | ||
| Public Comment | | Public Comment | ||
| 2017.09.15 | | 2017.09.15 | ||
| | | [[Media:QIBA_PET_Amyloid Comments_all resolved.xlsx| Public Comment Resolutions 2018-05-02]] | ||
|- | |- | ||
| [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]] | | [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]] | ||
Revision as of 18:33, 16 June 2020
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.